The TI:GER program at Georgia Tech teaches students that the main hurdles to commercializing research are seldom technology-related. More often they involve legal issues and problems interfacing with the public and market. TI:GER takes an interdisciplinary approach to surmounting those obstacles, assembling students who win acceptance into the highly competitive program into five member teams. These teams include two MBAs and two law students who focus on the commercialization of a PhD student's research over a two-year period.

***This program is supported by ACTSI and is administered by Georgia Institute of Technology.

2014 Supported Teams:

Team Viapore who is developing a surface-porous, medical imaging-compatible material that improves the osseointegration of polymeric implants. Team Viapore competed in Georgia Tech's Startup Competition where they were selected as 1 of 16 semi-finalists. They won first place at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress in Boston.

Team LymphaTech who is developing a technology that helps physicians determine the lymphatic health of breast cancer survivors. Team LympaTech competed in the Georgia Bowl Competition and won 3rd place. They also placed 6th in the prestigious Rice Business Plan Competition and placed as a semi-finalist in the New Venture Competition.

These teams are doing exciting work! Stay tuned for additional updates on team progress.

2015 Supported Team:

Team Bioletics' technology is designed to electrically stimulate nerves and control glucose levels.

Upcoming Events

View All Events

Training News

Training

MSCR Scholar Explores Sex Differences to Optimize HIV Treatment

Cecile Lahiri, MD, MSc, assistant professor, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, received an NIH K23 award for her work on defining antiretroviral pharmacology within HIV reservoirs of...

Training

KL2 Scholar Studies Novel Hematopoietic Stem Cell Approach to Sickle Cell Disease Treatment

Elizabeth Stenger, MD, MSc, assistant professor, Department of Pediatrics, Emory University School of Medicine, received a K23 award for her work on improving haploidentical hematopoietic stem cell transplantation in sickle cell disease using...